NEW YORK (GenomeWeb News) – German firm Mosaiques Diagnostics and Therapeutics has inked a contract with the US Food and Drug Administration to collaborate on the discovery and validation of biomarkers for assessing drug toxicity.

Under the partnership, the FDA will provide information about drugs, expected toxicities, and animal studies. Mosaiques will contribute its proteome analysis expertise, particularly in sample preparation of urine and capillary electrophoresis coupled mass spectrometry.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.